Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Reactions to Oil Crash & Coronavirus

The energy sector was already battered by the COVID-19 coronavirus when the oil price war began in earnest on Monday. Russia and OPEC couldn’t agree on production caps, Saudi Arabia decided to flood the market with oil and increase production, and the crash b...
Omri Wallach | March 11, 2020 |

Why Silver Stocks Should Be on Investors' Radar

Technical analyst Clive Maund explains why he believes investors should be looking at silver right now. We are now entering the final part of the endgame of the latest fiat experiment and the actions of the Fed and other central banks virtually guarantee that most ...
Streetwise Reports | May 22, 2020 |

Paper money rejection is gold’s Minsky Moment

In our last article ( A Minsky Moment is coming for gold ) we presented the “Minsky Moment”, referring to a point in time when a period of bullish speculation leads to a spectacular market crash. Named after economist Hyman Minsky, the theory centers...
Richard (Rick) Mills | February 24, 2020 |

Dermira's Phase 2b Atopic Dermatitis Trial Results Send Shares 25% Higher

Dermira shares traded higher today after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference. Yesterday afternoon, Dermira Inc. (DERM:NASDAQ) , a biopharmaceu...
Streetwise Reports | October 21, 2019 |

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....
Streetwise Reports | April 29, 2020 |

Buzz on the Bullboards: The ups and downs of the fall investing season

For us here on the West Coast it has been a hot autumn and the markets have been just as intense. This means Bullboard activity has also been sizzling. Many sectors have seen new (and returning) companies generate a lot of discussion as a result. This week we&CloseCur...
Jonathon Brown | October 13, 2022 |

What to do if you like QE3 but stocks make you nervous

QE2 in 2010 and ‘Operation Twist’ in 2011 recovered the stock market from double-digit corrections that were underway at the time, and rescued investors from their extreme bearish sentiment each time. QE3 is underway and many are convinced that&CloseCurlyQu...
Sy Harding | October 28, 2012 |

Buzz on the Bullboards: Debates in Top Sectors

Last week was a busy one for Canadian markets, to say the least. Alongside a spike for cannabis markets we saw the federal election cycle wrap with a Liberal Minority, and have started looking at what it means for investors. The Stockhouse Bullboards, in turn, were full ...
Omri Wallach | October 23, 2019 |

Real Estate Crash The Next Shoe To Drop – Part II

As we continue to delve into the looming Real Estate crisis that will likely hit the US and globe over the next 12 to 24+ months, we want to focus on the human psychological process of dealing with a crisis event and how that relates to economic engagement. In the first part...
Chris Vermeulen | April 23, 2020 |

Neurotrope's Shares Double on Phase 2 Alzheimer's Study Data and $2.7 Million NIH Grant

Neurotrope's shares traded higher today after reporting results from its Phase 2 "203" clinical trial of Byrostatin-1 for treatment of moderately severe to severe Alzheimer's patients. The firm has also been awarded a $2.7 million grant from the National Institutes of Health t...
Streetwise Reports | January 23, 2020 |
1 2 3 4 5 6 7 8 9 10 ...